Tyra Biosciences TYRA
NASDAQ TYRA
$21.21 -0.66 (-3.02%)
As of: Oct 1, 2026 · 1:01 PM EDT

Tyra Biosciences (TYRA) Other Non-Current Liabilities (2020 - 2024)

Updated

Tyra Biosciences (TYRA) posted Other Non-Current Liabilities of $3,000 for Q4 2024, down 93.5% from $46,000 a year earlier and down 72.7% from the prior quarter.

Analysis

Tyra Biosciences (TYRA) Other Non-Current Liabilities (2020 - 2024) Analysis & Trends

Since Q4 2020, Tyra Biosciences has reported Other Non-Current Liabilities for 15 quarters.

  • Annual Other Non-Current Liabilities has declined for three consecutive years, with a four-year compound annual growth rate of -61.7% (FY2020 to FY2024).
  • In prior years, Tyra Biosciences' Other Non-Current Liabilities was $46,000 in FY2023 (-72.8%), $169,000 in FY2022 (-54.0%), $367,000 in FY2021 (+162.1%) and $140,000 in FY2020.
  • The Q4 2024 figure stands as the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2020.
  • On a year-over-year basis, Other Non-Current Liabilities has declined in each of the last ten quarters, with an average decline of 73.9% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q4 2021, with growth of 162.1%; the weakest was Q4 2024, with a decline of 93.5%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $11,000 (Q3 2024), $20,000 (Q2 2024) and $29,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tyra Biosciences 1.30 Bn 1.30 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3,000.00
Sep 30, 2024 11,000.00
Jun 30, 2024 20,000.00
Mar 31, 2024 29,000.00
Dec 31, 2023 46,000.00
Sep 30, 2023 77,000.00
Jun 30, 2023 108,000.00
Mar 31, 2023 139,000.00
Dec 31, 2022 169,000.00
Sep 30, 2022 226,000.00
Jun 30, 2022 261,000.00
Mar 31, 2022 303,000.00
Dec 31, 2021 367,000.00
Sep 30, 2021 434,000.00
Dec 31, 2020 140,000.00
API Access

Tyra Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TYRA&period=max&api_key=YOUR_API_KEY